Orgenesis' market value is the price at which a share of Orgenesis trades on a public exchange. It measures the collective expectations of Orgenesis investors about its performance. Orgenesis is selling for under 0.6 as of the 30th of January 2026; that is 300.00 percent increase since the beginning of the trading day. The stock's lowest day price was 0.6. With this module, you can estimate the performance of a buy and hold strategy of Orgenesis and determine expected loss or profit from investing in Orgenesis over a given investment horizon. Check out Orgenesis Correlation, Orgenesis Volatility and Orgenesis Performance module to complement your research on Orgenesis.
It's important to distinguish between Orgenesis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Orgenesis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Orgenesis' market price signifies the transaction level at which participants voluntarily complete trades.
Orgenesis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Orgenesis' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Orgenesis.
0.00
11/01/2025
No Change 0.00
0.0
In 3 months and 1 day
01/30/2026
0.00
If you would invest 0.00 in Orgenesis on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Orgenesis or generate 0.0% return on investment in Orgenesis over 90 days. Orgenesis is related to or competes with Helix BioMedix. Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide More
Orgenesis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Orgenesis' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Orgenesis upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Orgenesis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Orgenesis' standard deviation. In reality, there are many statistical measures that can use Orgenesis historical prices to predict the future Orgenesis' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Orgenesis. Your research has to be compared to or analyzed against Orgenesis' peers to derive any actionable benefits. When done correctly, Orgenesis' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Orgenesis.
Orgenesis is out of control given 3 months investment horizon. Orgenesis maintains Sharpe Ratio (i.e., Efficiency) of 0.29, which implies the firm had a 0.29 % return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 35.6% are justified by taking the suggested risk. Use Orgenesis Risk Adjusted Performance of 0.2219, semi deviation of 30.29, and Coefficient Of Variation of 342.59 to evaluate company specific risk that cannot be diversified away. Orgenesis holds a performance score of 23 on a scale of zero to a hundred. The company holds a Beta of 19.18, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Orgenesis will likely underperform. Use Orgenesis sortino ratio and the relationship between the downside variance and period momentum indicator , to analyze future returns on Orgenesis.
Auto-correlation
-0.17
Insignificant reverse predictability
Orgenesis has insignificant reverse predictability. Overlapping area represents the amount of predictability between Orgenesis time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Orgenesis price movement. The serial correlation of -0.17 indicates that over 17.0% of current Orgenesis price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.17
Spearman Rank Test
-0.24
Residual Average
0.0
Price Variance
0.03
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Orgenesis Pink Sheet Analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.